Merlin Nexus is a private equity general partner firm headquartered in New York, NY, United States.
British early stage biotech cancer therapy company Adaptimmune has raised $104m from several PE firms.
VC-backed biopharmaceutical company Xencor has postponed its IPO for an unknown reason.
VC-backed Xencor, a biopharmaceutical company that provides engineered monoclonal antibodies, has filed for an IPO.
Read more news concerning Merlin Nexus
Registration is fast, free and easy
Already a member?